You are here: Home


27 | 07 | 16

Precision monitoring of more than 15 common cancers now feasible with GATCLIQUID ONCOTARGET

Liquid biopsy-based detection of crucial mutations associated with more than 15 prevalent cancer types Carefully selected target list...


13 | 07 | 16

Breaking new ground in transcriptomics: resolve full-length transcripts for unprecedented insights into novel isoforms and disease-causing splicing variants

Accurate profiling of genes and their previously inaccessible transcript isoforms Comprehensive exploration of transcript variability...


09 | 06 | 16

Liquid biopsy test - GATCLIQUID ONCOTARGET - expanded to cover blood cancers such as acute myeloid leukaemia

Worldwide unique service for highly sensitive profiling of the most relevant mutations for detection and management of  non-small cell...


11 | 05 | 16

GATC Biotech expands oncology product line with INVIEW ONCOPANEL for solid tumour profiling

Surveillance of 50 clinically relevant cancer genes  for targeted treatment of solid tumours  Treatment decision support for...


21 | 03 | 16

GATC Biotech’s liquid biopsy testing starts from as little as EUR 195 per sample

 GATC Biotech takes also the lead in terms of costs of liquid biopsy testing. GATCLIQUID services support early implementation of...



Visit us at conferences




9 - 12 July 2016 | Manchester, United Kingdom

EACR-24 - From Basic Research to Precision Medicine




7 -11 October 2016 | Copenhagen, Denmark

ESMO Congress


15 - 17 October 2016 | Leipzig, Germany



17 - 19 October 2016 | Paris, France

4th World Congress on Targeting Microbiota


Cooperate with us


Customized Solutions

Customized Solutions will perfectly match individual requests.

Look here for a made-to-order project design. Superb sequencing service, profound consultancy knowledge and 25 years of experience will lead you to your custom-fit approach.


Diagnostic Solutions

GATC Biotech as partner of trust within several international collaborations consolidated its expertise within Diagnostic Solutions

Expect state-of-the-art sequencing technologies, validated laboratory protocols and ISO 17025-accredited workflows. Receive reliable data, necessary know-how to succeed in the regulated market. 

Partner with us to realise the next generation of human diagnostics!



MYCOPLASMACHECK a PCR based assay to detect mycoplasma contamination in cell cultures.

Accurate - Reliable - Easy

Click here to learn more about GATC Biotech's quality control services and gain confidence in every cell culture.


The X-ray of the 21st century

Our GATCLIQUID service family offers cancer characterisation from a simple blood sample. Painful and costly tissue biopsies are replaced by non-invasive analysis of circulating tumour DNA (ctDNA). The so called liquid biopsy offers clinical researchers the opportunity to explore, screen and monitor a wide range of tumour-related mutations. This allows close surveillance of tumour dynamics and heterogeneity of a patient’s cancer.

Enter a new era of diagnostics with us!

Sequencing Solutions

Sequencing Solutions now groups our compelling Sanger sequencing services, our standardised INVIEW™ products as well as our novel modular NGSELECT.

The idea behind our Sequencing Solutions is to offer standardised one-stop solutions addressing the requirements from Sanger to NGS.



GATC Biotech introduces a novel modular system for next generation sequencing (NGS).

Build your own solution from pre-defined modules. 
Accompany us to the next level of NGS service.




Leading in Europe

GATC Biotech is Europe’s leading service provider of DNA sequencing with more than 10,000 academic and industrial customers worldwide.

For over two decades, we have offered sequencing and bioinformatics solutions from single samples up to large scale projects.

With all leading sequencing technologies installed in our own labs, we have sequenced more than 6 million samples, ten thousands of bacterial, plant and other whole genomes as well as hundreds of whole human genomes.

Copyright © 2016 GATC Biotech AG. All rights reserved.
RSS-Feed twitter facebook google plus linkedin xing